Vigil Health Solutions Inc. (TSX VENTURE:VGL) ("Vigil") announces the results of
operations for the quarter ending September 30, 2012.


Business Highlights 



--  Net Income of $32 thousand compared to a loss of $251 thousand in the
    three month period ended September 30, 2011. 
--  Grew bookings 18% to $1.27 million compared to $1.08 million in the
    three-month period ended September 30, 2011. 
--  Increased backlog to approximately $2.72 million (37 projects) compared
    to approximately $2.03 million (33 projects) in the three-month period
    ended September 30, 2011. 
--  Revenue up 24% to $826 thousand from $669 thousand in the three-months
    ended September 30, 2011. 
--  Reduced expenses by 34% to $363 from $547 thousand in the three-months
    ended September 30, 2011.



"This is the fifth consecutive quarter that we have seen increased sales
bookings year over year, a positive indicator moving forward. We are also
pleased that the measures taken to reduce costs while senior housing
construction recovers have resulted in a profitable quarter," stated Troy
Griffiths, President and CEO of Vigil Health Solutions Inc.


Financial Results

Revenue for the three-months ended September 30, 2012 was $826 thousand compared
to $669 thousand in the three-month period ended September 30, 2011, an increase
of 24%. Project revenue made up 57% of total revenue; the remaining revenue came
from follow on sales to existing customers. These sales include service and
maintenance billings and replacement products including wireless devices and
communication equipment.


Bookings for the quarter were $1.27 million up 18% compared to $1.08 million in
the three-month period ended September 30, 2011. Management believes this is an
indication of an improvement in the Senior Living industry.


At September 30, 2012 Vigil had a backlog of approximately $2.72 million
(including $836 thousand in deposits and progress billings, recorded as deferred
revenue on the balance sheet) a 34% increase compared to approximately $2.03
million (including $553 thousand in deposits and progress billings, recorded as
deferred revenue on the balance sheet) at September 30, 2011. At September 30,
2012, Vigil's backlog included 37 projects at varying stages of installation and
progress billing. The average project size was $74 thousand compared to 33
projects with an average value of $67 thousand in the three months ended
September 30, 2011. Projects can include individual buildings or floors of
multiple phase campus construction.


The gross margin percentage for the three months ended September 30, 2012 was
49% compared to 46% for the three months ended September 30, 2011. Gross margin
was slightly higher than management's usual expectations of margins of between
42% and 47%.


Expenditures for the three months ended September 30, 2012 were $363 thousand,
down 34% from $547 thousand for the period ended September 30, 2011. The
decrease is primarily due to lower costs reflecting lower staffing levels.


Net income for the three month period ended September 30, 2012 was $32 thousand,
or $0.002 per share compared to a loss of $251 thousand, or $0.019 per share for
the previous year. The profitable quarter relates largely to a decrease in
staffing levels and related expenses. The Company expects to see staffing levels
increase with bookings levels.


Detailed financial statements along with Management Discussion and Analysis have
been filed with SEDAR (www.sedar.com).


Financial information will be mailed to entitled security holders on November
23, 2012. Or, upon notice to the Company, entitled security holders may request
a copy of financials in advance.


Summary Financial Information



---------------------------------------------------------------------------
---------------------------------------------------------------------------
                                               September 30,  September 30,
                                                        2012           2011
---------------------------------------------------------------------------
                                                 (unaudited)    (unaudited)
                                                                           
Revenue                                             $826,434       $669,149
Cost of sales                                        423,838        360,146
---------------------------------------------------------------------------
                                                                           
                                                     402,596        309,003
                                                                           
Expenses                                             363,070        547,034
                                                                           
---------------------------------------------------------------------------
Income (loss) before the following items              39,526      (238,034)
                                                                           
Other income (expense):                              (7,362)       (13,123)
                                                                           
---------------------------------------------------------------------------
Income / (loss) for the period                       $32,164     $(251,157)
---------------------------------------------------------------------------
---------------------------------------------------------------------------



Non-IFRS Measure

For the three months ended September 30, 2012, we are disclosing Adjusted
EBITDA, a non-IFRS financial measure, as a supplementary indicator of operating
performance. We define Adjusted EBITDA as net income before, interest, income
taxes, amortization, stock based compensation and currency gains or losses
including derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it internally to make
strategic decisions, forecast future results and to evaluate our performance and
because we believe that our current and potential investors and analysts use the
measure to assess current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other companies
and it is not intended as a substitute for IFRS measures.


Adjusted EBITDA Reconciliation



---------------------------------------------------------------------------
---------------------------------------------------------------------------
                                                   Three months ended      
                                               September 30,  September 30,
                                                        2012           2011
---------------------------------------------------------------------------
                                                                           
Income / (loss) for the period                       $32,164     $(251,157)
                                                                           
Add / (deduct)                                                             
  Foreign exchange                                    11,062       (18,100)
  Derivative exchange                                (7,858)         29,050
  Interest                                             4,158          2,173
  Stock based compensation                            12,643          1,994
  Amortization                                         3,812          6,164
  -------------------------------------------------------------------------
                                                      23,817         21,281
                                                                           
---------------------------------------------------------------------------
Adjusted EBITDA                                      $55,981     $(229,876)
---------------------------------------------------------------------------
---------------------------------------------------------------------------



About Vigil Health Solutions Inc.

Vigil offers a proprietary technology platform combining software and hardware
to provide comprehensive solutions to the expanding seniors' housing market.
Vigil has established a growing presence in North America and an international
reputation for being on the leading edge of systems design and integration.
Vigil's objective is to offer solutions for the full continuum of care. Vigil's
product range includes the innovative wireless Vitality Care System(TM)
featuring discreet 'mini pendants', a nurse call system, mobile fall,
incontinence monitoring, resident check and the award-winning Vigil Dementia
System.


Certain statements contained in this news release that are not based on
historical facts may constitute forward-looking statements or forward-looking
information within the meaning of applicable securities laws ("forward-looking
statements"). These forward-looking statements are not promises or guarantees of
future performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown risks,
assumptions, uncertainties and other factors that could cause our actual
results, performance, achievements or developments in our business or in our
industry to differ materially from those expressed, anticipated or implied by
such forward-looking statements.


Forward-looking statements include all financial guidance, disclosure regarding
possible events, conditions, circumstances or results of operations that are
based on assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they are made. These
forward-looking statements appear in a number of different places in this
presentation and can be identified by words such as "may", "estimates",
"projects", "expects", "intends", "believes", "plans", "anticipates", or their
negatives or other comparable words. Forward-looking statements include
statements regarding the outlook for our future operations, plans and timing for
the introduction or enhancement of our services and products, statements
concerning strategies or developments, statements about future market
conditions, supply conditions, end customer demand conditions, channel inventory
and sell through, revenue, gross margin, operating expenses, profits, forecasts
of future costs and expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical fact.


The risk factors and uncertainties that may affect our actual results,
performance, achievements or developments are many and include, amongst others,
our ability to develop our sales force and generate revenue, the length of the
sales cycle, management of the Company's growth, ability to recruit and retain
staff, fluctuations in demand for current and future products, our ability to
develop, manufacture, supply and market existing and new products that meet the
needs of customers, volatility in the exchange rate, ability to secure
financing, ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others are discussed
in the Risks and Uncertainties section of our "Management Discussion and
Analysis" segment of our fiscal 2012 Annual Report. Many of these factors and
uncertainties are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by this cautionary
statement and there can be no assurance that actual results, performance,
achievements or developments anticipated by the Company will be realized.


Forward-looking statements are based on management's current plans, estimates,
projections, beliefs and opinions and, except as required by law, the Company
does not undertake any obligation to update forward-looking statements should
the assumptions related to these plans, estimates, projections, beliefs and
opinions change.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Vigil Health Solutions Inc.
Troy Griffiths
President and CEO
(250) 383-6900
(250) 383-6999 (FAX)
information@vigil.com
www.vigil.com

Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.
Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.